Browse by Speaker

Type here to filter the list

P
Pace, E

Department of Radiology, The Royal Marsden NHS Foundation Trust
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
E Pace
Favorite
Palassini, Elena

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Elena Palassini
Favorite
Palmerini, Emanuela

IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
Session 14: Bone Sarcomas
Location: VCC, East Exhibition Hall A
Emanuela Palmerini
Favorite
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Emanuela Palmerini
Favorite
Palmer, Joshua

The James Cancer Hospital at the Ohio State University
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Joshua Palmer
Favorite
Pal, Rajesh

Precision Sarcoma Research Group
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Rajesh Pal
Favorite
Pan, Irene

United BioSource LLC
Paper 87 - PATIENT-REPORTED SYMPTOM IMPROVEMENT IN PATIENTS TREATED WITH PEXIDARTINIB FOR TENOSYNOVIAL GIANT CELL TUMOR: A CROSS-SECTIONAL SURVEY IN THE UNITED STATES
Irene Pan
Favorite
Pantaleo, Maria

DIMES
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Maria Pantaleo
Favorite
Pappo, Alberto

Department of Oncology, St. Jude Children's Research Hospital
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Alberto Pappo
Favorite
Park, Peter J

Department of Biomedical Informatics, Harvard Medical School
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Peter J Park
Favorite
Partington, Karen

Oxford University Hospital NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Karen Partington
Favorite
Pasquali, Sandro

Molecular Pharmacology Unit, Department of Research and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Sandro Pasquali
Favorite
Patel, Jaymin
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Jaymin Patel
Favorite
Patel, Manish R.

Sarah Cannon Research Institute, Florida Cancer Specialists & Research Institute
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Manish R. Patel
Favorite
Patel, Shreyaskumar

The University of Texas MD Anderson Cancer Center
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Shreyaskumar Patel
Favorite
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Shreyaskumar Patel
Favorite
Patil, Vijay

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Vijay Patil
Favorite
Patin, Emmanuel

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Emmanuel Patin
Favorite
Pawel, Bruce

Children's Hospital Los Angeles
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Bruce Pawel
Favorite
Pedersen, Malin

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Malin Pedersen
Favorite
Percio, Stefano

Fondazione IRCCS Istituto Nazionale Tumori
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Stefano Percio
Favorite
Perhavec, Andraz

Institute of Oncology Ljubljana
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Andraz Perhavec
Favorite
Periyapatna, Nivitha

University of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Nivitha Periyapatna
Favorite
Perkins, Susan

Indiana University Department of Biostatistics and Health Data Science
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Susan Perkins
Favorite
Perreault, Sébastien

Department of Neurosciences, CHU Sainte Justine
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Sébastien Perreault
Favorite
Perrone, Federica

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Federica Perrone
Favorite
Pestana, Roberto

Hospital Israelita Albert Einstein
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Roberto Pestana
Favorite
Peterfy, Charles

Spire Sciences, Boca Raton, FL, USA
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Charles Peterfy
Favorite
Petersen, Ivy

Mayo Clinic
Paper 39 - PENCIL BEAM SCANNING PROTON RADIOTHERAPY FOR SACRAL CHORDOMAS: THE MAYO CLINIC EXPERIENCE
Ivy Petersen
Favorite
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Ivy Petersen
Favorite
Peterson, Nicholas

University of California, Los Angeles
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Nicholas Peterson
Favorite
Peul, Wilco

University Neurosurgical Centre Holland, LUMC
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Wilco Peul
Favorite
Phillips, Marianne

Perth Children's Hospital
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Marianne Phillips
Favorite
Piculell, Katherine

Division of Genetics and Genomics, Boston Children’s Hospital
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Katherine Piculell
Favorite
Pierron, Gaelle

Institut Curie - Paris, FRANCE
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Gaelle Pierron
Favorite
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Gaelle Pierron
Favorite
Pilco-Janeta, Daniel F.

Brigham and Women's Hospital
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Daniel F. Pilco-Janeta
Favorite
Pillay, Nischalan

University College London and Royal National Orthopaedic Hospital
Session 5: Diagnostic Advances (Radiology, Pathology, Molecular)
Location: VCC, East Exhibition Hall A
Nischalan Pillay
Favorite
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Nischalan Pillay
Favorite
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Nischalan Pillay
Favorite
Podleska, Lars

Essen University Hospital
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Lars Podleska
Favorite
Polak, Samuel

University Neurosurgical Centre Holland, LUMC
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Samuel Polak
Favorite
Poole, Bella

Moffitt
Paper 06 - EVOLUTIONARY TUMOR BOARD (NCT04343365) AS A MODEL FOR MOVING FORWARD: METASTATIC EWING SARCOMA
Bella Poole
Favorite
Poppe, Matthew

University of Utah Huntsman Cancer Institute
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Matthew Poppe
Favorite
Porfilio, Timothy

Department of Pediatrics, University of Colorado
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Timothy Porfilio
Favorite
Porpiglia, Andrea

Fox Chase Cancer Center
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Andrea Porpiglia
Favorite
Posey, Kristi

The University of Texas MD Anderson Cancer Center
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Kristi Posey
Favorite
Poultsides, George

Stanford
Paper 83 - DEVELOPMENT OF A PROGNOSTIC NOMOGRAM TO PREDICT 30-DAY READMISSION IN LOCALIZED SOFT TISSUE SARCOMAS OF THE EXTREMITY
George Poultsides
Favorite
Prabhash, Kumar

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Kumar Prabhash
Favorite
Principe, Miguel Alfonso

Lunenfeld-Tanenbaum Research Institute
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Miguel Alfonso Principe
Favorite
Prochazka, Patrick

Duke University School of Medicine
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Patrick Prochazka
Favorite
Prologo, David J

Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
David J Prologo
Favorite
Proszek, Paula

Clinical Genomics Translational Research, Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Paula Proszek
Favorite
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Paula Proszek
Favorite
Provenzano, Salvatore

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Salvatore Provenzano
Favorite
Przybyl, Joanna

McGill University
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Joanna Przybyl
Favorite
Puertas, Pablo

Hospital Universitario Virgen de la Arrixaca
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Pablo Puertas
Favorite